Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
CONCLUSIONS: Tremendous progress has been made for the discovery of type I interferonopathies and responsible genes. Janus kinase inhibitors and other agents have potential therapeutic roles. Future basic, translational and clinical studies towards disease monitoring and powerful therapies are warranted.
PMID: 31377974 [PubMed - as supplied by publisher]
Source: World Journal of Pediatrics : WJP - Category: Pediatrics Authors: Yu ZX, Song HM Tags: World J Pediatr Source Type: research
More News: Autoimmune Disease | Dermatitis | Dermatology | Genetics | Interstitial Lung Disease | Pediatrics | Skin | Study